Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Globe Life Inc is an insurance-life business based in the US. Globe Life shares (GL) are listed on the NYSE and all prices are listed in US Dollars. Globe Life employs 3,261 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$89.67|
|52-week range||$74.61 - $107.78|
|50-day moving average||$94.54|
|200-day moving average||$98.60|
|Wall St. target price||$108.43|
|Dividend yield||$0.77 (0.84%)|
|Earnings per share (TTM)||$7.32|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-09-10)||-2.56%|
|1 month (2021-08-19)||-5.48%|
|3 months (2021-06-18)||-2.80%|
|6 months (2021-03-19)||-9.39%|
|1 year (2020-09-18)||8.74%|
|2 years (2019-09-19)||-4.93%|
|3 years (2018-09-19)||2.87%|
|5 years (2016-09-19)||39.96%|
Valuing Globe Life stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Globe Life's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Globe Life's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 12x. In other words, Globe Life shares trade at around 12x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Globe Life's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.1 billion.
The EBITDA is a measure of a Globe Life's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$5 billion|
|Operating margin TTM||20.89%|
|Gross profit TTM||$1.3 billion|
|Return on assets TTM||2.27%|
|Return on equity TTM||9.37%|
|Market capitalisation||$9.1 billion|
TTM: trailing 12 months
There are currently 1.0 million Globe Life shares held short by investors – that's known as Globe Life's "short interest". This figure is 6.8% up from 949,303 last month.
There are a few different ways that this level of interest in shorting Globe Life shares can be evaluated.
Globe Life's "short interest ratio" (SIR) is the quantity of Globe Life shares currently shorted divided by the average quantity of Globe Life shares traded daily (recently around 290479.94269341). Globe Life's SIR currently stands at 3.49. In other words for every 100,000 Globe Life shares traded daily on the market, roughly 3490 shares are currently held short.
However Globe Life's short interest can also be evaluated against the total number of Globe Life shares, or, against the total number of tradable Globe Life shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Globe Life's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Globe Life shares in existence, roughly 10 shares are currently held short) or 0.0109% of the tradable shares (for every 100,000 tradable Globe Life shares, roughly 11 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Globe Life.
Find out more about how you can short Globe Life stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Globe Life.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 26.98
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Globe Life's overall score of 26.98 (as at 12/31/2018) is pretty good – landing it in it in the 38th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Globe Life is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 5.59/100
Globe Life's environmental score of 5.59 puts it squarely in the 8th percentile of companies rated in the same sector. This could suggest that Globe Life is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 16.11/100
Globe Life's social score of 16.11 puts it squarely in the 8th percentile of companies rated in the same sector. This could suggest that Globe Life is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 16.77/100
Globe Life's governance score puts it squarely in the 8th percentile of companies rated in the same sector. That could suggest that Globe Life is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 1/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Globe Life scored a 1 out of 5 for controversy – the highest score possible, reflecting that Globe Life has managed to keep its nose clean.
|Total ESG score||26.98|
|Total ESG percentile||38.22|
|Environmental score percentile||8|
|Social score percentile||8|
|Governance score percentile||8|
|Level of controversy||1|
Dividend payout ratio: 11.5% of net profits
Recently Globe Life has paid out, on average, around 11.5% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.88% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Globe Life shareholders could enjoy a 0.88% return on their shares, in the form of dividend payments. In Globe Life's case, that would currently equate to about $0.77 per share.
While Globe Life's payout ratio might seem low, this can signify that Globe Life is investing more in its future growth.
Globe Life's most recent dividend payout was on 31 October 2021. The latest dividend was paid out to all shareholders who bought their shares by 30 September 2021 (the "ex-dividend date").
Globe Life's shares were split on a 3:2 basis on 1 July 2014. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Globe Life shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Globe Life shares which in turn could have impacted Globe Life's share price.
Over the last 12 months, Globe Life's shares have ranged in value from as little as $74.6082 up to $107.775. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Globe Life's is 1.1441. This would suggest that Globe Life's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Globe Life Inc. , through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers whole life, term life, and other life insurance products; Medicare supplement and supplemental health insurance, such as critical illness and accident plans; and single-premium and flexible-premium deferred annuities. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc.
Everything we know about the MiNK Therapeutics IPO, plus information on how to buy in.
Everything we know about the Wetouch Technology IPO, plus information on how to buy in.
Everything we know about the Life Time Group Holdings IPO, plus information on how to buy in.
Everything we know about the Slinger Bag IPO, plus information on how to buy in.
Everything we know about the NSTS Bancorp IPO, plus information on how to buy in.
Everything we know about the Volcon IPO, plus information on how to buy in.
Everything we know about the Thomas James Homes IPO, plus information on how to buy in.
Everything we know about the FGI Industries IPO, plus information on how to buy in.
Everything we know about the Zhong Yang Financial Group IPO, plus information on how to buy in.
Everything we know about the Exscientia Ltd IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.